Navigation Links
GlaxoSmithKline Reports Further Progress of Oncology Portfolio
Date:4/22/2008

New Data For Presentation At ASCO 2008

LONDON and PHILADELPHIA, April 22 /PRNewswire/ -- GlaxoSmithKline Oncology will present a wide range of new data at the annual American Society of Clinical Oncology (ASCO) meeting in Chicago starting Friday, May 30th. The data cover a variety of therapies, experimental medicines and immunotherapeutics for the treatment and supportive care of cancer patients. At this year's ASCO meeting, GSK Oncology will present data that demonstrate trends in cancer research, including the combination of targeted therapies and a focus on oral treatment options.

GSK will make data presentations for TYKERB(R) (lapatinib), which is approved in more than 20 countries, including the US. The US indication is in combination with capecitabine for the treatment of patients with advanced or metastatic breast cancer whose tumors overexpress HER2/ErbB2 and who have received prior therapy including an anthracycline, a taxane, and trastuzumab.

New data will also be presented for HYCAMTIN(R) (topetecan HCl). GSK will also present data for several investigational medicines, including the oral multikinase angiogenesis inhibitor, ARMALA(TM) (pazopanib); the neurokinin-1 receptor antagonist, REZONIC(TM) (casopitant); the oxidative stress inducer, elesclomol and the antigen-specific cancer immunotherapeutic, MAGE-A3 ASCI.

Highlights of the GSK Oncology data to be presented at ASCO include:

Breast Cancer

A randomized study of lapatinib (TYKERB) in combination with trastuzumab vs. lapatinib monotherapy in heavily pretreated HER2+ metastatic breast cancer progressing on trastuzumab therapy [Phase III]Dr. Joyce O'Shaughnessy, Baylor-Sammons Cancer Center, Texas Oncology, PA, US Oncology, Dallas, TX, abstract # 1015, oral presentation, Sunday, June 01, 2008, 9:15 am - 9:30 am, E-Hall D1

Randomized study of pazopanib + lapatinib vs. lapatinib alone in patients with HER2+ advanced or metastatic brea
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Paul Capital Healthcare Purchases Additional Royalty Interest in GlaxoSmithKlines Rotarix(R)
2. GlaxoSmithKline and Theravance Announce Start of Large Phase 2B ICS and LABA Studies for Asthma in the Horizon Program
3. Coley Pharmaceutical Group Receives $3.0 Million Milestone Payment from GlaxoSmithKline
4. New Data Show That GlaxoSmithKlines Rotarix(R) Could Be Given With Other Routine Infant Vaccines in the U.S.
5. GlaxoSmithKline Accelerates Review of Exelixis XL880
6. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
7. Isis Reports Reduction of apoB-100 Levels in a Murine Model Resulting in Up to 92% Reduction of Atherosclerosis
8. Sunesis Pharmaceuticals Reports Data from Nonclinical Studies of SNS-032 at the Annual Meeting of the American Association for Cancer Research
9. Novavax Reports Positive Results from Preclinical Studies of its VLP-based Trivalent Seasonal Influenza Vaccine Candidate
10. Pharmacyclics Reports Multiple Presentations at AACR on Its HDAC and Selective HDAC Inhibitors
11. Medarex Reports Interim Data from Ongoing Ipilimumab Combination Phase 1 Studies in Prostate Cancer at American Association for Cancer Research Meeting

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...MINNEAPOLIS, Nov. 30 Nonin Medical...oring solutions and the inventor of fingertip puls...North American Product Line Strategy Award in Remo...cure, accurate remote physiological monitoring, No... a premier provider of telemedicine monitoring equ...
(Date:11/30/2009)...AGO, Nov. 30 Breast-Specific Gamma...sitive imaging technique for the detection of duct...se breast cancer. BSGI is a molecular breast imagi...issue density and discover very early stage cancer...nual meeting of the Radiological Society of North ...
(Date:11/30/2009)...NTO, Nov. 30 The Special Committee...n" or the "Company") (TSX: PTI) and JLL Partners, ...(collectively, "JLL"), today announced that the Co...ment in respect of the pending legal actions betwe...ong other things that: ,, until March 2011, th...
Breaking Medicine Technology:Nonin Medical is Recognized by Frost & Sullivan for Remote Patient Monitoring Leadership 2Nonin Medical is Recognized by Frost & Sullivan for Remote Patient Monitoring Leadership 3Breast-Specific Gamma Imaging Proves Highly Sensitive for the Detection of Ductal Carcinoma In Situ 2Patheon and JLL Partners Announce Litigation Settlement 2Patheon and JLL Partners Announce Litigation Settlement 3Overall Health of U S Children a Mixed Bag 51315 1Overall Health of U S Children a Mixed Bag 51315 2Overall Health of U S Children a Mixed Bag 51315 3Overall Health of U S Children a Mixed Bag 51315 4Team Develops Anti Infection Technology 51311 1Team Develops Anti Infection Technology 51311 2Connectyx Looks to Establish Market Leadership with MedSync and MedFlash Product Line As Stated During Nationwide Teleconference 51307 1Connectyx Looks to Establish Market Leadership with MedSync and MedFlash Product Line As Stated During Nationwide Teleconference 51307 2Connectyx Looks to Establish Market Leadership with MedSync and MedFlash Product Line As Stated During Nationwide Teleconference 51307 3
...gonist to Advance for Treatment of Allergy , , SA..., a biopharmaceutical company focused on the devel...ts for the treatment of cancer, respiratory and in...nitiated a Phase I clinical trial of VTX-1463, a s... of allergic rhinitis. The objectives of this tria...
...with special recognition awarded to top-rated abst...ceuticals, a pioneer in the development of novel p...t and treat human disease, announced that the comp...hnology will be the focus of three poster sessions...Association for Cancer Research (AACR) meeting. Th...
Other Medicine Technology:VentiRx Pharmaceuticals Initiates Phase I Clinical Trial of VTX-1463, a Novel TLR8 Agonist for the Treatment of Allergic Rhinitis 2Cequent tkRNAi Technology to be Presented at the Centennial Meeting of the American Association for Cancer Research 2Cequent tkRNAi Technology to be Presented at the Centennial Meeting of the American Association for Cancer Research 3
(Date:12/1/2009)... , ADDISON, Texas, Dec. 1 For...nsive health care is more than just an employee be...y of employees. Hobby Lobby Stores, Inc. is leadin...ing a worksite health and wellness center at its c...health care services directly to employees and the...
(Date:12/1/2009)... , BRUSSELS, December 1 ...Agree That Adapting Food,Production and Modes of A..., Prof. John Beddington, Chief Scientific A...icultural policy must be founded on science and ha...fic advisor with the,responsibility to look at all...
(Date:12/1/2009)...ising vaccine trial, better access to treatment wo...SDAY, Dec. 1 (HealthDay News) -- While the war aga...rove to be a watershed year in terms of advances i...act, earlier this month a United Nations report fo...obally has remained unchanged, at about 33 million...
(Date:12/1/2009)... The Centers for Disease Cont...United States is born with an autism spectrum diso...and improve sensory processing by playing the new ...unt from Vision Audio, Inc., a wonderful holiday g... Joppa, MD (PRWEB) December 1...
(Date:12/1/2009)... NYC based physician Dr. Mich...nal book, "The Perfect 10 Diet: 10 Key Hormon...ng Great--Fast!" (Source books Jan. 2110). T...low-carb and popular diets disturb hormones, and p...ss efforts by balancing hormones. , ...
Breaking Medicine News(10 mins):Health News:Hobby Lobby Selects Concentra to Open Health Center 2Health News:Hobby Lobby Selects Concentra to Open Health Center 3Health News:Food Security to be the Top Issue for EU's Science Chief 2Health News:A Good Year in the Fight Against AIDS 2Health News:A Good Year in the Fight Against AIDS 3Health News:A Good Year in the Fight Against AIDS 4Health News:EASe Funhouse Video Game Helps Children with Autism Learn to Improve Sensory Processing 2Health News:EASe Funhouse Video Game Helps Children with Autism Learn to Improve Sensory Processing 3Health News:EASe Funhouse Video Game Helps Children with Autism Learn to Improve Sensory Processing 4Health News:Dr. Michael Aziz Releases a New Nutrition Book That Debunks Most Popular Diets and Diet Books 2Health News:Dr. Michael Aziz Releases a New Nutrition Book That Debunks Most Popular Diets and Diet Books 3
... and smoke-free work environment play key roles in...way from cigarettes, a study has found. T...niversity, who also found that environmental facto...moking cessation attempts often are thought of as ...
...at adopting a healthier lifestyle in middle age lo...Researchers from the Medical University of South C...o 64 years of age, who took up healthy lifestyle b...drop in CVD frequency and a 40 percent decrease in...
...Chris Benoit said Friday that he was eager to see ... killed his wife and son and committed suicide. ...d seven-year-old Daniel was found in their home in... a double murder-suicide. His father Mich...
...fflict humans very early, not sparing even tiny to...r anxiety disorders in New South Wales in Australi...e prevalent than depression, figures released by M...t 1 per cent for mood disorders such as depression...
...od Programme (WFP) today announced plans to assist... needs of people living in communities affected b... food assistance due to the persistence of the dro...in Dili, Timor Leste. A recent food secur...
...n Institute for Medical Research have identified a...determine the fertility of a man. Dr. Yo...hage migration inhibitory factor (MIF) is the key ...they may lead to a diagnostic test to determine fe...
Other Medicine News:Health News:Smoke-free Workplace, Non-smoking Spouse Help Quitters Stay Off the Butt 2Health News:Adopting Healthy Lifestyle in Middle Age Lowers Heart Disease Risk 2Health News:Toxicology Test Will Give Me Answers-Benoits Dad 2Health News:Anxiety Disorders Show in Tiny Tots 2
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
Medicine Products: